![]() |
市場調査レポート
商品コード
1533651
バイオマテリアルの市場規模、シェア、成長分析:タイプ別、用途別、地域別 - 産業予測、2024年~2031年Biomaterials Market Size, Share, Growth Analysis, By Type (Natural Biomaterial, Metallic Biomaterial), Application (Neurology, Cardiology), By Region - Industry Forecast 2024-2031 |
||||||
|
バイオマテリアルの市場規模、シェア、成長分析:タイプ別、用途別、地域別 - 産業予測、2024年~2031年 |
出版日: 2024年08月05日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
|
バイオマテリアルの市場規模は、2022年に1,354億米ドルとなり、2023年の1,559億米ドルから、2031年までには4,381億米ドルに成長し、予測期間(2024年~2031年)のCAGRは15.4%で成長する見通しです。
バイオマテリアルは、合成か天然かを問わず、損傷した組織や臓器の機能を改善するために医療技術で使用される人工材料です。損なわれた生物学的機能を補強、置換、サポートすることで、ヘルスケアにおいて重要な役割を果たしています。これらの材料は、金属、セラミック、プラスチック、ポリマー、あるいは生きた細胞や組織から得られることもあります。一般的な用途としては、心臓弁、ステント、移植片、人工関節、靭帯、腱、歯科インプラントなどの医療用インプラントや、縫合糸、クリップ、組織修復を助けるドラッグ・デリバリー・システムなどがあります。バイオマテリアル市場の成長の促進力は、整形外科や創傷治癒における使用の増加、心臓血管、神経、整形外科疾患の罹患率の上昇、高齢者人口の増加、移植可能なデバイスの需要の増加、革新的なバイオマテリアル開発のための政府や学術機関からの資金提供の増加などです。
Biomaterials Market size was valued at USD 135.4 billion in 2022 and is poised to grow from USD 155.9 billion in 2023 to USD 438.1 billion by 2031, growing at a CAGR of 15.4% in the forecast period (2024-2031).
Biomaterials, whether synthetic or natural, are engineered materials used in medical technology to improve the function of damaged tissues and organs. They play a crucial role in healthcare by helping to augment, replace, or support impaired biological functions. These materials can be derived from metals, ceramics, plastics, polymers, or even living cells and tissues. Common applications include medical implants like heart valves, stents, grafts, artificial joints, ligaments, tendons, and dental implants, as well as sutures, clips, and drug delivery systems that aid in tissue repair. The growth of the biomaterials market is driven by several factors: increasing use in plastic surgery and wound healing, rising incidences of cardiovascular, neurological, and orthopedic conditions, a growing elderly population, higher demand for implantable devices, and increased funding from governments and academic institutions for the development of innovative biomaterials.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biomaterials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Biomaterials Market Segmental Analysis
The global biomaterials market is segmented based on type, application, and region. Based on the type, the market is segmented into natural biomaterial, metallic biomaterial, ceramic biomaterial, and polymeric biomaterial. Based on the application, the market is segmented as neurology, cardiology, orthopedics, ophthalmology, wound care, dental, plastic surgery, and other applications. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Drivers of the Global Biomaterials Market
A major driver of growth in the biomaterials industry is the increased funding and grants provided by government agencies and universities for the development of innovative biomaterials. In recent years, the demand and application of biomaterials have significantly risen globally. To support this trend, numerous government bodies and institutions have offered financial assistance, including investments and grants, to foster research and development in this field. For instance, the National Science Foundation awarded Drexel University $200,000 to investigate how biomaterial-mediated control of macrophage behavior impacts biomaterial vascularization. Such funding and research initiatives are expected to accelerate the development of new biomaterials, presenting substantial growth opportunities for the market.
Restraints in the Global Biomaterials Market
A significant challenge to the growth of the biomaterials industry is the stringent clinical and regulatory processes that govern their approval. Biomaterials, particularly those used in implantable medical devices, are subject to rigorous safety and efficacy requirements before they can be marketed. In the United States, the FDA imposes strict standards for these approvals. Devices such as implantable pacemakers, stents, and cardiac valves are classified as Class III by the FDA, which signifies the highest level of risk. Consequently, these devices must undergo the premarket approval (PMA) process, which is the most stringent device marketing application procedure. These rigorous regulations can slow down the market's growth by extending development timelines and increasing costs.
Market Trends of the Global Biomaterials Market
A prominent trend in the global biomaterials market is the growing demand for biomaterials in plastic surgery and wound healing applications. As the population increases and the costs associated with treating damaged or diseased organs rise, implantable devices are increasingly favored for their proven clinical efficacy. These devices are used as scaffolds for restoring both soft and hard tissue deformities, offering significant benefits in wound healing. They promote tissue growth, maintain volume and shape, and accelerate healing times. Major players in the industry are expanding their product offerings for these applications through strategic partnerships and acquisitions. For instance, Advanced Medical Solutions (AMS), a company specializing in surgical and wound care, acquired Biomatlante, a firm focused on surgical biomaterial technologies.